Filing Details
- Accession Number:
- 0001209191-15-070350
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-11 16:53:46
- Reporting Period:
- 2015-08-19
- Filing Date:
- 2015-09-11
- Accepted Time:
- 2015-09-11 16:53:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585666 | A. Allen Fienberg | C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016 | Vp Of Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-09 | 12,500 | $1.36 | 295,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-08-19 | 10,000 | $30.30 | 198,023 | No | 4 | S | Indirect | Held by J.D.F. Holdings Ltd. |
Common Stock | Disposition | 2015-08-21 | 200 | $30.30 | 197,823 | No | 4 | S | Indirect | Held by J.D.F. Holdings Ltd. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Indirect | Held by J.D.F. Holdings Ltd. |
No | 4 | S | Indirect | Held by J.D.F. Holdings Ltd. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-09-09 | 12,500 | $0.00 | 12,500 | $1.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2006-12-05 | No | 4 | M | Direct |
Footnotes
- Dr. Fienberg holds a 20% ownership interest in J.D.F. Holdings Ltd. and may be deemed to beneficially own the securities held by J.D.F. Holdings Ltd. Dr. Fienberg disclaims beneficial ownership of the securities held by J.D.F. Holdings Ltd. except to the extent of his pecuniary interest therein.
- All shares underlying this option have vested.